"It's a lab-ready system – that's really critical," Geraldine Hamilton, president and chief scientific officer of Emulate Inc., told BioWorld Today, detailing the firm's cooperative research and development agreement with the FDA for use of the Boston-based firm's Organs-on-Chips technology, which will be placed "in [the FDA's] lab, so they can get first-hand experience" with it.